GATC Health President Dr. Rahul Gupta Honored with 2026 SCALE Community Podcast Award
IRVINE, Calif., October 16, 2026 – Rahul Gupta, MD, MPH, MBA, President of GATC Health, was honored as the recipient of the 2026 SCALE Community Podcast Award in the Innovation category for his standout appearance on the Analyzing Healthcare podcast. The award was presented at an exclusive industry event and reception held in New York City. Recipients were selected based on the substance of the discussion, specifically recognizing the profound insight, clarity, and importance Dr. Gupta brought to the topic. His featured episode highlighted how artificial intelligence can redefine the economics of drug discovery and healthcare. You can listen to the award-winning conversation by visiting the episode here.
Dr. Rahul Gupta on stage at the SCALE Healthcare Leadership Summit in New York City on October 13, 2026.
About GATC
GATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% sensitivity. Trusted by the world’s largest insurance marketplace, biopharma, researchers, and investment partners, GATC Health’s risk prediction product, the Derisq™ AI report, accurately assesses and predicts drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. GATC Health’s AI platform is also generative, creating novel intellectual property, extending pipelines, and optimizing assets. By uniting advanced AI, multiomics, and predictive modeling, GATC Health accelerates breakthroughs and reduces costly late-stage failures to bring safer, more effective therapies to patients worldwide. For more information, visit www.gatchealth.com.
Contact Us
Similar News
GATC Health Receives Concentrated Media Visibility Across AI, Capital Markets and Regulatory Policy Conversations
April 7, 2026 — GATC Health received a strong run of media attention over the past two weeks, with six notable inclusions across BioSpace a…
Read more
GATC Health and UC Irvine Announce Landmark PNAS Publication Validating AI-Platform for Opioid Use Disorder Treatment
April 07, 2026 (GLOBE NEWSWIRE) — GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform d…
Read more
Fierce Biotech: AI model designs new treatment candidate for opioid addiction that cuts cravings in rats
April 6, 2026 Fierce Biotech: AI model designs new treatment candidate for opioid addiction that cuts cravings in rats By Darren Incor…
Read more